Joint FDA Advisory Committee Votes Not to Recommend Pain Therapeutics’ Oxycodone NDA By Sam | June 26, 2018 Remoxy ER, Pain Therapeutics’ new oxycodone pain relief candidate, failed to sway FDA advisory committee members this week. Source: Drug Industry Daily Posted in Drug Industry Daily